- Consultancy specializing in corporate strategy, business development, public policy/government relations, and advocacy - Business strategy development to support 7 to 9-figure growth, M&A, public policy/government relations and issue advocacy

-Led day-to-day operations, execution of strategic plan, and scaling of 8-figure SaaS company that automates and transforms accounting industry with best-in-class accounting software tools-Developed structures, processes, and policies to align with and build on company’s vision and strategy-Led organizational optimization/expansion and corporate transformation endeavors in due diligence process as part of 4-member C-Suite/leadership team, in preparation for 10/23 private equity acquisition

- 3-year, non-remunerative leadership assignment by senior Church leaders to preside over the México Chalco Mission- Train, mentor and attend to the physical, emotional, and spiritual needs and safety of 400-500 full-time, volunteer, Gen Z/Millennial missionaries from throughout the Americas, serving in the states of México and Morelos- Consistently train and develop leadership capabilities of missionaries through monthly leadership conferences and weekly one-on-one coaching and small group sessions- Regularly train, support and mentor local Church leadership and 30,000+ members in 56 local congregations- Minister to and address the temporal and spiritual needs of the Mexican people in economically challenged environments during a global pandemic- Oversee and manage organizational budgets and capital assets

- Temptime acquired by Zebra Technologies from private equity/Water Street Healthcare Partners – Feb 2019- Head of global health policy, advocacy, and government relations; member of leadership team- Collaborated with the FDA, GS1, and U.S. lawmakers and legislative co-sponsors of the U.S. Drug Quality Security Act and Drug Supply Chain Security Act to enhance implementation efforts related to 2D barcodes and temperature sensing technologies and drug anti-counterfeiting policy development and implementation- Partnered with governments of United States (FDA), Mexico, Brazil, Perú, and Argentina on 2D barcode and temperature sensing policy development and proof of concept pilots

- Executive Team Leader - company acquired by private equity (Water Street Healthcare Partners)- Strategy formulation and implementation – resulting in significant EBITDA growth and successful exit (acquisition by Zebra Technologies)-Formulation of domestic and international health and supply-chain strategies and policies (incorporating temperature sensing technologies to improve patient safety, vaccine & biologic efficacy, and global public health access, resulting in enhanced product integrity and quality in supply chains and reduced product wastage and product falsification)-Corporate liaison to state, provincial, federal and international government officials, agency leaders, global health policymakers, and non-governmental organizations: e.g., WHO, UNICEF, GAVI, PATH, PAHO, Gates Foundation, Sabin Vaccine Institute, PhRMA, IFPMA, WTO, DCVMN, U.S. Congress, FDA, CDC, etc. - Partnership with FDA agency leaders (Commissioner Scott Gottlieb), GS1, U.S. lawmakers and legislative co-sponsors of U.S. Drug Quality Security Act and Drug Supply Chain Security Act to enhance implementation efforts related to 2D barcodes and temperature sensing technologies to prevent product counterfeiting and wastage- Partnership with GS1, GAVI, WHO, UNICEF, BMGF, and government agency heads in US (FDA, CDC, & HHS), Mexico, Brazil, Perú, Argentina, and Africa region on 2D barcode, anti-counterfeiting, drone delivery, and supply chain policies & proof of concept pilots

- Relocated to Merck HQ when LATAM regional office in Brazil was closed due to security concerns- Vaccine policy & advocacy lead to policymakers, agencies, coalitions, thought leaders and institutions -Team lead to federal agencies on health disparities/health equity initiatives (CDC, HHS, & Office of Women’s Health)

-Recruited by head of global vaccine policy (former health policy advisor to President Bill Clinton) to relocate to São Paulo, Brazil to lead health policy teams and strategic initiatives, such as national HPV vaccine introductions-Formulation and implementation of regional vaccine & HIV strategic vision and policies, resulting in numerous new government commitments to long-term contracts to expand vaccine HIV/ARV access to 300M people --Successful advocacy efforts, resulting in region’s first-ever contract, prioritization, and purchase by PAHO’s revolving fund and governments in Latin America & Caribbean region of Merck’s vaccine portfolio and anti-retrovirals-Leader & mentor to Spanish and Portuguese-speaking HIV/vaccine policy, government affairs, and comms teams-Member of regional corporate leadership team with emphasis on HPV vaccine introductions throughout region--Ownership and direction of fiscally-sound, sustainable long-range planning processes, with integrated regional policy/advocacy/lobbying budgets in support of priority HIV/vaccine/women’s & children’s health & IP/trade objectives-Creation & significant expansion of Merck’s regional/country presence as company’s principal/lead to key stakeholders (WHO/Pan American Health Organization, International AIDS Vaccine Initiative, U.N. Population Fund, WTO, MERCOSUR/UNASUR, IFPMA, Gates Foundation, PATH, Sabin Vaccine Institute, & Organization of American States)

-Vaccine policy & advocacy lead to agencies, academic thought leaders, universities & targeted governors, first spouses, and staffers to partner and prioritize strategic public health/vaccine access initiatives with emphasis on child & maternal health, MSM communities, and state-wide HPV/cancer elimination initiatives in 12-state region & Puerto Rico-Strategic initiatives/policy resource development, analysis, research, & liaison to state legislatures & targeted governors within National Governors’ Association & RGA/DGA (e.g. – Jindal, Romney, Huckabee, Perry, Napolitano, etc.) -Development & oversight of state vaccine legislation/regulation, resulting in successful passage of laws expanding vaccine access and state vaccine infrastructure appropriations in largest population/large ethnic minority states (TX/FL) -Liaison to Senator Chuck Grassley & staff in response to inquiry regarding Merck’s nationwide HPV/cervical cancer policy & advocacy initiatives-Development & communication of burden of illness/epidemiological data/briefs/talking points to secure Medicaid, 317, & Vaccines For Children federal funding in support of key vaccine initiatives for targeted states (worked with local congressional offices of Jeff Flake, Orrin Hatch, Raul Labrador, etc.)-Creation of effective strategic partnerships with key opinion leaders, academic institutions, and state health officials/policymakers to promulgate pro-innovation/pro-access rules/regulations at state health departments level as alternative to legislation-Development of position papers, health policy analyses, health economics/outcomes research, key disease/issue backgrounders, and presentations to Merck leadership regarding proposed policy initiatives and strategies related to key public health issues at state and federal levels-Development and translation of vaccine policy resources from English to Spanish for use by Hispanic legislators & policymakers in key states

-Development of key relationships with targeted state health policymakers and state vaccine thought leaders - Idaho/eastern Washington-Facilitation of strategic meetings with Merck leadership & policy teams, Idaho medical thought leaders, and state public health policymakers to initiate varicella school-entry requirement discussions & improve pediatric/adult vaccine utilization-Development of targeted vaccine access strategies and successful public health collaboration between Merck & health policymakers, resulting in first-ever inclusion of Merck’s combination Hib-HepB vaccine in Idaho immunization program -Development of relationships of trust with physicians, academics, & targeted state health policymakers and state vaccine thought leaders throughout Idaho/eastern Washington to prioritize childhood vaccination initiatives-2001 Vice President’s Club Award for significant national public health impact & exceeding divisional objectives-2000 Rookie of the Year Award for noteworthy vaccine/public health impact in region & exceeding objectives

-Immigration advocacy, policy development, and strategic implementation for international law firm (Bacon & Merritt, LLP/Bryan Cave, LLP) as third-party contractor to billion-dollar corporate clients (Motorola/Intel) - until absorbed/acquired by Motorola-Lobbying of President Bill Clinton’s staff and key members of Congress (Rep. Lamar Smith, R-TX) for expanded corporate immigration benefits, resulting in passage of bipartisan, pro-technology industry (Motorola/Intel) federal immigration legislation with expanded H-1B visa quotas and employment rights for specialized international hi-tech workers-Corporate liaison to federal agencies (Immigration & Naturalization Service and Dept. of Labor) and policymakers-Pro-bono advocacy for Spanish-speaking migrant workers & immigrants with pending, family-based immigration cases-Corporate/firm lead on translation/interpretation services for Spanish & Portuguese-speaking clients and liaison to LULAC and Hispanic Federation